Skip to main content
. 2014 Aug 25;8(5):2313–2317. doi: 10.3892/ol.2014.2477

Figure 1.

Figure 1

ANXA9 mRNA expression in clinical tissue specimens. Reverse transcription-quantitative polymerase chain reaction on 100 paired clinical samples showed that 56 of these cases (56.0%) exhibited higher levels of ANXA9 mRNA in the tumor samples compared with the paired normal tissues. The mean ANXA9 mRNA expression level in the tumor tissues (normalized by GAPDH gene expression) was not significantly different compared with that of the corresponding normal tissues (P=0.239, Wilcoxon’s rank test). ANXA9, annexin A9; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.